2016-11393. Manufacturer of Controlled Substances Registration: Organix, Inc.  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    Organix, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Organix, Inc. registration as a manufacturer of those controlled substances.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    By notice dated November 27, 2015, and published in the Federal Register on December 3, 2015, 80 FR 75691, Organix, Inc., 240 Salem Street, Woburn, Massachusetts 01801 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice.

    The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Organix, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances:

    Controlled substanceSchedule
    Gamma Hydroxybutyric Acid (2010)I
    Marihuana (7360)I
    Tetrahydrocannabinols (7370)I
    Psilocybin (7437)I
    Psilocyn (7438)I
    Heroin (9200)I
    Lysergic acid diethylamide (7315)II
    Morphine (9300)II

    The company plans to manufacture reference standards for distribution to its research and forensics customers. In reference to drug codes 7360 (marihuana) and 7370 (THC) the company plans to manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Dated: May 9, 2016.

    Louis J. Milione,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2016-11393 Filed 5-13-16; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
05/16/2016
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of registration.
Document Number:
2016-11393
Pages:
30343-30343 (1 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2016-11393.pdf